ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Choroidal Neovascularization Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-8W12383
Home | Market Reports | Health| Vision Care
Global Choroidal Neovascularization Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Choroidal Neovascularization Market Research Report 2024

Code: QYRE-Auto-8W12383
Report
January 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc
Bayer
QLT
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc
Bausch Health
Gilead Sciences Inc

Choroidal Neovascularization Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Choroidal Neovascularization Market

Choroidal Neovascularization Market

Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Choroidal Neovascularization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroidal Neovascularization.

Report Scope

The Choroidal Neovascularization market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Choroidal Neovascularization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Choroidal Neovascularization manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Choroidal Neovascularization Market Report

Report Metric Details
Report Name Choroidal Neovascularization Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Intravenous
  • Intravitreal
Segment by Application
  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, QLT Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Promedior Inc., Bausch Health, Gilead Sciences Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Choroidal Neovascularization manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Choroidal Neovascularization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Choroidal Neovascularization Market report?

Ans: The main players in the Choroidal Neovascularization Market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, QLT Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Promedior Inc., Bausch Health, Gilead Sciences Inc

What are the Application segmentation covered in the Choroidal Neovascularization Market report?

Ans: The Applications covered in the Choroidal Neovascularization Market report are Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments

What are the Type segmentation covered in the Choroidal Neovascularization Market report?

Ans: The Types covered in the Choroidal Neovascularization Market report are Intravenous, Intravitreal

1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Global Choroidal Neovascularization Market Value by Application: (2024-2030)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2019-2030
1.4.2 Global Choroidal Neovascularization Sales 2019-2030
1.4.3 Global Choroidal Neovascularization Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2019-2024)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2019-2024)
2.4 Global Choroidal Neovascularization Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application
2.7 Choroidal Neovascularization Market Competitive Situation and Trends
2.7.1 Choroidal Neovascularization Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.7.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Choroidal Neovascularization Global Choroidal Neovascularization Sales by Region: 2019-2030
3.2.1 Global Choroidal Neovascularization Sales by Region: 2019-2024
3.2.2 Global Choroidal Neovascularization Sales by Region: 2025-2030
3.3 Global Choroidal Neovascularization Global Choroidal Neovascularization Revenue by Region: 2019-2030
3.3.1 Global Choroidal Neovascularization Revenue by Region: 2019-2024
3.3.2 Global Choroidal Neovascularization Revenue by Region: 2025-2030
3.4 North America Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 North America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Choroidal Neovascularization Sales by Country (2019-2030)
3.4.3 North America Choroidal Neovascularization Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.5.1 Europe Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Choroidal Neovascularization Sales by Country (2019-2030)
3.5.3 Europe Choroidal Neovascularization Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Asia Pacific Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Choroidal Neovascularization Sales by Country (2019-2030)
3.6.3 Asia Pacific Choroidal Neovascularization Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Latin America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Choroidal Neovascularization Sales by Country (2019-2030)
3.7.3 Latin America Choroidal Neovascularization Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.8.1 Middle East and Africa Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Choroidal Neovascularization Sales by Country (2019-2030)
3.8.3 Middle East and Africa Choroidal Neovascularization Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Choroidal Neovascularization Sales by Type (2019-2030)
4.1.1 Global Choroidal Neovascularization Sales by Type (2019-2024)
4.1.2 Global Choroidal Neovascularization Sales by Type (2025-2030)
4.1.3 Global Choroidal Neovascularization Sales Market Share by Type (2019-2030)
4.2 Global Choroidal Neovascularization Revenue by Type (2019-2030)
4.2.1 Global Choroidal Neovascularization Revenue by Type (2019-2024)
4.2.2 Global Choroidal Neovascularization Revenue by Type (2025-2030)
4.2.3 Global Choroidal Neovascularization Revenue Market Share by Type (2019-2030)
4.3 Global Choroidal Neovascularization Price by Type (2019-2030)
5 Segment by Application
5.1 Global Choroidal Neovascularization Sales by Application (2019-2030)
5.1.1 Global Choroidal Neovascularization Sales by Application (2019-2024)
5.1.2 Global Choroidal Neovascularization Sales by Application (2025-2030)
5.1.3 Global Choroidal Neovascularization Sales Market Share by Application (2019-2030)
5.2 Global Choroidal Neovascularization Revenue by Application (2019-2030)
5.2.1 Global Choroidal Neovascularization Revenue by Application (2019-2024)
5.2.2 Global Choroidal Neovascularization Revenue by Application (2025-2030)
5.2.3 Global Choroidal Neovascularization Revenue Market Share by Application (2019-2030)
5.3 Global Choroidal Neovascularization Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Choroidal Neovascularization Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Choroidal Neovascularization Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Choroidal Neovascularization Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.6.4 QLT Inc. Choroidal Neovascularization Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Promedior Inc. Choroidal Neovascularization Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bausch Health Choroidal Neovascularization Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gilead Sciences Inc Choroidal Neovascularization Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Choroidal Neovascularization Industry Chain Analysis
7.2 Choroidal Neovascularization Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Choroidal Neovascularization Production Mode & Process
7.4 Choroidal Neovascularization Sales and Marketing
7.4.1 Choroidal Neovascularization Sales Channels
7.4.2 Choroidal Neovascularization Distributors
7.5 Choroidal Neovascularization Customers
8 Choroidal Neovascularization Market Dynamics
8.1 Choroidal Neovascularization Industry Trends
8.2 Choroidal Neovascularization Market Drivers
8.3 Choroidal Neovascularization Market Challenges
8.4 Choroidal Neovascularization Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc
Bayer
QLT
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc
Bausch Health
Gilead Sciences Inc
List of Tables
    Table 1. Global Choroidal Neovascularization Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Choroidal Neovascularization Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Choroidal Neovascularization Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Choroidal Neovascularization Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Choroidal Neovascularization Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Choroidal Neovascularization Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Choroidal Neovascularization, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application
    Table 12. Global Key Manufacturers of Choroidal Neovascularization, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Choroidal Neovascularization Sales by Region (2019-2024) & (K Units)
    Table 18. Global Choroidal Neovascularization Sales Market Share by Region (2019-2024)
    Table 19. Global Choroidal Neovascularization Sales by Region (2025-2030) & (K Units)
    Table 20. Global Choroidal Neovascularization Sales Market Share by Region (2025-2030)
    Table 21. Global Choroidal Neovascularization Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Choroidal Neovascularization Revenue Market Share by Region (2019-2024)
    Table 23. Global Choroidal Neovascularization Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Choroidal Neovascularization Revenue Market Share by Region (2025-2030)
    Table 25. North America Choroidal Neovascularization Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
    Table 27. North America Choroidal Neovascularization Sales by Country (2025-2030) & (K Units)
    Table 28. North America Choroidal Neovascularization Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Choroidal Neovascularization Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Choroidal Neovascularization Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Choroidal Neovascularization Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Choroidal Neovascularization Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Choroidal Neovascularization Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Choroidal Neovascularization Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Choroidal Neovascularization Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Choroidal Neovascularization Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Choroidal Neovascularization Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Choroidal Neovascularization Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Choroidal Neovascularization Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Choroidal Neovascularization Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Choroidal Neovascularization Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Choroidal Neovascularization Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Choroidal Neovascularization Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Choroidal Neovascularization Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Choroidal Neovascularization Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Choroidal Neovascularization Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Choroidal Neovascularization Sales (K Units) by Type (2019-2024)
    Table 51. Global Choroidal Neovascularization Sales (K Units) by Type (2025-2030)
    Table 52. Global Choroidal Neovascularization Sales Market Share by Type (2019-2024)
    Table 53. Global Choroidal Neovascularization Sales Market Share by Type (2025-2030)
    Table 54. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Choroidal Neovascularization Revenue Market Share by Type (2019-2024)
    Table 57. Global Choroidal Neovascularization Revenue Market Share by Type (2025-2030)
    Table 58. Global Choroidal Neovascularization Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Choroidal Neovascularization Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Choroidal Neovascularization Sales (K Units) by Application (2019-2024)
    Table 61. Global Choroidal Neovascularization Sales (K Units) by Application (2025-2030)
    Table 62. Global Choroidal Neovascularization Sales Market Share by Application (2019-2024)
    Table 63. Global Choroidal Neovascularization Sales Market Share by Application (2025-2030)
    Table 64. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Choroidal Neovascularization Revenue Market Share by Application (2019-2024)
    Table 67. Global Choroidal Neovascularization Revenue Market Share by Application (2025-2030)
    Table 68. Global Choroidal Neovascularization Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Choroidal Neovascularization Price (USD/Unit) by Application (2025-2030)
    Table 70. Pfizer Inc. Corporation Information
    Table 71. Pfizer Inc. Description and Business Overview
    Table 72. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Inc. Choroidal Neovascularization Product
    Table 74. Pfizer Inc. Recent Developments/Updates
    Table 75. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 76. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 77. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product
    Table 79. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
    Table 80. Novartis AG Corporation Information
    Table 81. Novartis AG Description and Business Overview
    Table 82. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis AG Choroidal Neovascularization Product
    Table 84. Novartis AG Recent Developments/Updates
    Table 85. Regeneron Pharmaceuticals Inc. Corporation Information
    Table 86. Regeneron Pharmaceuticals Inc. Description and Business Overview
    Table 87. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product
    Table 89. Regeneron Pharmaceuticals Inc. Recent Developments/Updates
    Table 90. Bayer AG Corporation Information
    Table 91. Bayer AG Description and Business Overview
    Table 92. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Bayer AG Choroidal Neovascularization Product
    Table 94. Bayer AG Recent Developments/Updates
    Table 95. QLT Inc. Corporation Information
    Table 96. QLT Inc. Description and Business Overview
    Table 97. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. QLT Inc. Choroidal Neovascularization Product
    Table 99. QLT Inc. Recent Developments/Updates
    Table 100. Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
    Table 101. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
    Table 102. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product
    Table 104. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
    Table 105. Promedior Inc. Corporation Information
    Table 106. Promedior Inc. Description and Business Overview
    Table 107. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Promedior Inc. Choroidal Neovascularization Product
    Table 109. Promedior Inc. Recent Developments/Updates
    Table 110. Bausch Health Corporation Information
    Table 111. Bausch Health Description and Business Overview
    Table 112. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Bausch Health Choroidal Neovascularization Product
    Table 114. Bausch Health Recent Developments/Updates
    Table 115. Gilead Sciences Inc Corporation Information
    Table 116. Gilead Sciences Inc Description and Business Overview
    Table 117. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Gilead Sciences Inc Choroidal Neovascularization Product
    Table 119. Gilead Sciences Inc Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Choroidal Neovascularization Distributors List
    Table 123. Choroidal Neovascularization Customers List
    Table 124. Choroidal Neovascularization Market Trends
    Table 125. Choroidal Neovascularization Market Drivers
    Table 126. Choroidal Neovascularization Market Challenges
    Table 127. Choroidal Neovascularization Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Choroidal Neovascularization
    Figure 2. Global Choroidal Neovascularization Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Choroidal Neovascularization Market Share by Type in 2023 & 2030
    Figure 4. Intravenous Product Picture
    Figure 5. Intravitreal Product Picture
    Figure 6. Global Choroidal Neovascularization Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Choroidal Neovascularization Market Share by Application in 2023 & 2030
    Figure 8. Extreme Myopia
    Figure 9. Malignant Myopic Degeneration
    Figure 10. Age-Related Developments
    Figure 11. Global Choroidal Neovascularization Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Choroidal Neovascularization Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Choroidal Neovascularization Sales (2019-2030) & (K Units)
    Figure 14. Global Choroidal Neovascularization Average Price (USD/Unit) & (2019-2030)
    Figure 15. Choroidal Neovascularization Report Years Considered
    Figure 16. Choroidal Neovascularization Sales Share by Manufacturers in 2023
    Figure 17. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Choroidal Neovascularization Players: Market Share by Revenue in 2023
    Figure 19. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Choroidal Neovascularization Sales Market Share by Country (2019-2030)
    Figure 22. North America Choroidal Neovascularization Revenue Market Share by Country (2019-2030)
    Figure 23. United States Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Mexico Choroidal Neovascularization Revenue Growth Rate (2019-2024) & (US$ Million)
    Figure 26. Europe Choroidal Neovascularization Sales Market Share by Country (2019-2030)
    Figure 27. Europe Choroidal Neovascularization Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. UK Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Choroidal Neovascularization Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Choroidal Neovascularization Revenue Market Share by Region (2019-2030)
    Figure 35. China Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Vietnam Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Choroidal Neovascularization Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Choroidal Neovascularization Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Choroidal Neovascularization Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Choroidal Neovascularization by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Choroidal Neovascularization by Type (2019-2030)
    Figure 57. Global Choroidal Neovascularization Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Choroidal Neovascularization by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Choroidal Neovascularization by Application (2019-2030)
    Figure 60. Global Choroidal Neovascularization Price (USD/Unit) by Application (2019-2030)
    Figure 61. Choroidal Neovascularization Value Chain
    Figure 62. Choroidal Neovascularization Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Plano-Convex Lenses Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16D8497
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Corneal Analyzer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35S2767
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cranio Maxillofacial Fixation Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23O9114
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ocular Surface Analyzers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31P3498
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions